107 related articles for article (PubMed ID: 19889300)
21. Diagnosis and management costs of suspicious skin lesions from a population-based melanoma screening programme.
Gordon L; Youl PH; Elwood M; Janda M; Ring IT; Lowe JB; Aitken JF
J Med Screen; 2007; 14(2):98-102. PubMed ID: 17626710
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of the diagnosis of pigmented tumors of the skin and factors leading to a decision to excise. Dermatologists of the Postgraduate Association of Haute-Normandie].
Collas H; Delbarre M; De Preville PA; Courville P; Neveu C; Dompmartin A; Balguerie X; Lemaistre B; Rzeznik JC; Thiebot B; Boullie MC; Bravard P; Michel Y; Krug M; Le Corvaisier-Pieto C; Young P; Thomine E; Boivin C; Ziade J; Pellerin A; Hellot MF; Leroy D; Lauret P; Benichou J; Joly P
Ann Dermatol Venereol; 1999; 126(6-7):494-500. PubMed ID: 10495858
[TBL] [Abstract][Full Text] [Related]
23. The association between hospital outcomes and diagnostic imaging: early findings.
Lee DW; Foster DA
J Am Coll Radiol; 2009 Nov; 6(11):780-5. PubMed ID: 19878885
[TBL] [Abstract][Full Text] [Related]
24. Costs of the detection of metastases and follow-up examinations in cutaneous melanoma.
Leiter U; Marghoob AA; Lasithiotakis K; Eigentler TK; Meier F; Meisner C; Garbe C
Melanoma Res; 2009 Feb; 19(1):50-7. PubMed ID: 19430406
[TBL] [Abstract][Full Text] [Related]
25. [Bottom-up analysis of the case costs of stem cell transplantation and selected chemotherapies].
Stäbler W; Wagner B
Klin Padiatr; 2003; 215(3):179-84. PubMed ID: 12778360
[TBL] [Abstract][Full Text] [Related]
26. Malignant melanoma: cost and reimbursement issues.
Creagan ET
Semin Oncol; 1989 Feb; 16(1 Suppl 1):45-50. PubMed ID: 2465576
[TBL] [Abstract][Full Text] [Related]
27. Clinical pathways to diagnose melanoma: a population-based study.
Baade PD; Youl PH; English DR; Mark Elwood J; Aitken JF
Melanoma Res; 2007 Aug; 17(4):243-9. PubMed ID: 17625455
[TBL] [Abstract][Full Text] [Related]
28. [Dermatologists should take care of suspected malignant melanoma].
Larkö O
Lakartidningen; 2008 Sep 24-30; 105(39):2659. PubMed ID: 18846870
[No Abstract] [Full Text] [Related]
29. [Comparing individual costs for treatment in acute day and inpatient care--results from a randomised controlled trial].
Kallert TW; Schönherr R; Fröhling D; Schützwohl M
Psychiatr Prax; 2007 Nov; 34(8):377-83. PubMed ID: 17671918
[TBL] [Abstract][Full Text] [Related]
30. Referral pattern and accuracy of clinical diagnosis of cutaneous melanoma.
Rampen FH; Rümke P
Acta Derm Venereol; 1988; 68(1):61-4. PubMed ID: 2449014
[TBL] [Abstract][Full Text] [Related]
31. [Cancer of the kidney in adults. Economic aspects].
Prog Urol; 1997 Nov; 7(5):901-4. PubMed ID: 9458486
[No Abstract] [Full Text] [Related]
32. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma.
Fisher NM; Schaffer JV; Berwick M; Bolognia JL
J Am Acad Dermatol; 2005 Sep; 53(3):393-406. PubMed ID: 16112344
[TBL] [Abstract][Full Text] [Related]
33. [Economic aspects of diagnosis, treatment and rehabilitation of patients with malignant skin neoplasms].
Stranadko EF; Aleksandrova LA; Khadzhiev MA
Sov Med; 1990; (9):39-40. PubMed ID: 2148438
[No Abstract] [Full Text] [Related]
34. Estimated Healthcare Costs of Melanoma in Australia Over 3 Years Post-Diagnosis.
Elliott TM; Whiteman DC; Olsen CM; Gordon LG
Appl Health Econ Health Policy; 2017 Dec; 15(6):805-816. PubMed ID: 28756584
[TBL] [Abstract][Full Text] [Related]
35. Cost of Cutaneous Melanoma by Tumor Stage: A Descriptive Analysis.
Serra-Arbeloa P; Rabines-Juárez ÁO; Álvarez-Ruiz MS; Guillén-Grima F
Actas Dermosifiliogr; 2017 Apr; 108(3):229-236. PubMed ID: 27887672
[TBL] [Abstract][Full Text] [Related]
36. Comparative healthcare costs in patients with metastatic melanoma in the USA.
Chang CL; Schabert VF; Munakata J; Donga P; Abhyankar S; Reyes CM; Yim YM
Melanoma Res; 2015 Aug; 25(4):312-20. PubMed ID: 25882026
[TBL] [Abstract][Full Text] [Related]
37. Cost-of-illness of melanoma in Europe - a systematic review of the published literature.
Krensel M; Schäfer I; Augustin M
J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):504-510. PubMed ID: 30408246
[TBL] [Abstract][Full Text] [Related]
38. Stage-specific direct health care costs in patients with cutaneous malignant melanoma.
Lyth J; Carstensen J; Synnerstad I; Lindholm C
J Eur Acad Dermatol Venereol; 2016 May; 30(5):789-93. PubMed ID: 25807966
[TBL] [Abstract][Full Text] [Related]
39. Estimation of Direct Melanoma-related Costs by Disease Stage and by Phase of Diagnosis and Treatment According to Clinical Guidelines.
Buja A; Sartor G; Scioni M; Vecchiato A; Bolzan M; Rebba V; Sileni VC; Palozzo AC; Montesco M; Del Fiore P; Baldo V; Rossi CR
Acta Derm Venereol; 2018 Feb; 98(2):218-224. PubMed ID: 29110018
[TBL] [Abstract][Full Text] [Related]
40. [Analysis of hemodynamics costs. A multicenter study based on consumed resources].
Alonso Gutiérrez M; Tascón Pérez J; Andreu Dussac J; González-Trevilla A
Rev Esp Cardiol; 1995 Apr; 48(4):245-54. PubMed ID: 7740145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
